Physician profile
Ryan Devenyi
NPI 1356845770
$9,846.44
in general payments reported to CMS, 2019-2025
19 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $9,147 · 2024: $168 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,000 · Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,000.00 |
| Food and Beverage | $846.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,000.00 | 2023 | |
| Medtronic, INC. | $219.14 | 2023-2025 | Percept PC Brainsense |
| Abbvie INC. | $117.66 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $96.31 | 2024-2025 | Austedo Xr, Austedo Xr |
| Acadia Pharmaceuticals INC | $51.16 | 2024-2025 | Nuplazid |
| Sk Life Science, INC. | $47.99 | 2024-2025 | |
| Ucb, INC. | $43.88 | 2025 | Nayzilam, Zilbrysq, Rystiggo |
| Impel Pharmaceuticals LLC | $37.45 | 2025 | Trudhesa |
| Neurocrine Biosciences, INC. | $35.53 | 2025 | |
| Lundbeck LLC | $32.97 | 2025 | Vyepti |
| Ipsen Biopharmaceuticals, INC | $29.56 | 2024-2025 | Dysport |
| Genentech USA, INC. | $20.62 | 2025 | Ocrevus Zunovo |
| Merz Pharmaceuticals, LLC | $19.09 | 2024 | Xeomin |
| Mdd US Operations, LLC | $18.88 | 2025 | |
| Amneal Pharmaceuticals LLC | $18.52 | 2025 | Crexont |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $17.02 | 2025 | Horizant |
| Kyowa Kirin, INC. | $14.96 | 2024 | Nourianz |
| Eisai INC. | $14.55 | 2025 | |
| Aucta Pharmaceuticals, INC. | $11.15 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Devenyi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.